On June 5, 2024 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that management will participate in a fireside chat at the 45TH Annual Goldman Sachs Global Healthcare Conference to take place June 10-13, 2024 (Press release, UroGen Pharma, JUN 5, 2024, View Source [SID1234644143]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs 45TH Annual Healthcare Conference

Date/ time:

June 11, 2024 at 3:20 PM ET

Format:

Fireside Chat

Location:

Miami, FL

Webcast Link:

here

A webcast from the conference will also be available via the Investors section of UroGen’s corporate website, View Source A replay will be available for approximately 90 days.